Matthew Webb

Matthew Webb is currently the Global Lead for Vyndaqel at Pfizer and serves as the Global Rare Disease Artificial Intelligence & Future Growth Lead. Previously, they held various positions at Pfizer, including Director of Regional Strategy & Operations for Oncology and European Oncology Brand Manager. Before joining Pfizer, Matthew worked at AstraZeneca as a Medical Sales Representative and Global Brand Associate for CRESTOR. They earned an Executive MBA from Imperial College London and a BA in Management Studies from the University of Nottingham.